Brett A. Giffin

Insider Reports History

Entity
Individual
Location
101 Hartwell Ave., Lexington, MA
Signature
/s/ John Sprague, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brett A. Giffin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
T2 Biosystems, Inc. Chief Commercial Officer Restricted Stock Units 180K $28.4K $0.16 Nov 4, 2024 Direct
T2 Biosystems, Inc. Chief Commercial Officer Common Stock 77 $12.00 $0.16 Feb 20, 2024 Direct

Insider Reports Filed by Brett A. Giffin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TTOO T2 Biosystems, Inc. Nov 4, 2024 2 $0 4 Jan 2, 2025 Chief Commercial Officer
TTOO T2 Biosystems, Inc. Feb 20, 2024 2 $0 4 Feb 20, 2024 Chief Commercial Officer
TTOO T2 Biosystems, Inc. Nov 8, 2023 2 $0 4 Nov 28, 2023 Chief Commercial Officer
TTOO T2 Biosystems, Inc. Feb 20, 2023 3 -$349 4/A Nov 28, 2023 Chief Commercial Officer
TTOO T2 Biosystems, Inc. Nov 8, 2022 3 -$2.32K 4 Nov 22, 2022 Chief Commercial Officer
TTOO T2 Biosystems, Inc. Apr 8, 2022 1 $5.18K 4 Apr 11, 2022 Chief Commercial Officer
TTOO T2 Biosystems, Inc. Feb 26, 2022 1 $0 4 Mar 30, 2022 Chief Commercial Officer
TTOO T2 Biosystems, Inc. Feb 20, 2022 1 $0 4 Feb 23, 2022 Chief Commercial Officer
TTOO T2 Biosystems, Inc. Nov 8, 2021 0 $0 3/A Mar 30, 2022 Chief Commercial Officer